Water for injection (WFI) is used in the pharmaceutical industry to formulate parenteral drugs and for cleaning and other manufacturing operations. Reverse osmosis followed by a polishing step can be a more efficient and cost-effective solution for WFI production.
In the pursuit of efficiency, productivity and staying ahead of the competition, we often seem to chase the next piece of shiny equipment or inventive approach, but sometimes, a good old-fashioned method applied in a different way can provide an innovative and effective solution. When it comes to cooling pharmaceutical facilities and their processes, we don’t necessarily need the most modern refrigeration technology.
Too often, the term “closed process” is thrown around without an understanding of the salient issues. Process closure can certainly provide many benefits, but there are various impacts and requirements depending on the ultimate goal and the specific process you are trying to close.
With the biopharmaceutical industry facing patent expirations and increasing competition, now more than ever, processing equipment designs, such as mixing tanks, need to be developed quickly and efficiently and work correctly the first time.
Manufacturers, especially contract manufacturing organizations, have recently faced challenges to provide numerous small inventories to achieve first-to-market penetration. As more products vie for manufacturing space, manufacturers are exploring options for providing a diverse mixture of formulations from their facilities all at once.